GNMK - GenMark Diagnostics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
75,080
70,759
52,519
49,274
39,411
Cost of Revenue
51,742
51,278
32,514
19,700
15,317
Gross Profit
23,338
19,481
20,005
29,574
24,094
Operating Expenses
Research Development
26,121
27,931
42,760
49,458
37,472
Selling General and Administrative
41,217
39,322
36,762
29,097
28,157
Total Operating Expenses
67,338
67,253
79,522
78,555
65,629
Operating Income or Loss
-44,000
-47,772
-59,517
-48,981
-41,535
Interest Expense
4,327
3,108
3,042
1,536
880
Total Other Income/Expenses Net
-105
-192
249
-160
133
Income Before Tax
-47,798
-50,361
-61,749
-50,501
-42,157
Income Tax Expense
146
139
101
100
40
Income from Continuing Operations
-47,944
-50,500
-61,850
-50,601
-42,197
Net Income
-47,944
-50,500
-61,850
-50,601
-42,197
Net Income available to common shareholders
-47,944
-50,500
-61,850
-50,601
-42,197
Reported EPS
Basic
-
-0.91
-1.21
-1.15
-1.00
Diluted
-
-0.91
-1.21
-1.15
-1.00
Weighted average shares outstanding
Basic
-
55,669
51,169
44,100
42,157
Diluted
-
55,669
51,169
44,100
42,157
EBITDA
-
-40,165
-53,390
-45,049
-37,872